Share on

In this week’s video, Dr. Brian G.M. Durie discusses what BiTEs are and how they may help achieve a response in patients with myeloma. 

BOTTOM LINE:
BiTEs are new monoclonal antibody forms of therapy and have very encouraging early results.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org

Previous Post
How Do You Tell If You're in Remission?
Next Post
Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.